Kulvinder Kochar Kaur*
Scientific Director, DR Kulvinder Kaur Centre For Human Reproduction, Jalandhar, Punjab, India
*Corresponding Author: Kulvinder Kochar Kaur, Scientific Director, DR Kulvinder Kaur Centre For Human Reproduction, Jalandhar, Punjab, India.
Received: April 25, 2020; Published: April 30, 2020
Type 1 diabetes mellitus (T1D) represents roughly 5 - 10% of all diabetic patients. Prevalence of this pathology points that > 500,000 children suffer from T1D globally, that are located mostly in North America as well as Europe [1]. But the epidemiology points that the incidence of T1D has escalated rapidly in recent years [2]. In 2017, the International Diabetes Federation (IDF) declared 132,600 newly diagnosed T1D cases all over the world. It is predicted that incidence of T1D in ≤ 5yr age will increase 2 fold in less than 20yrs
Citation: Kulvinder Kochar Kaur. “Attempting Getting Insulin Independent Immunotherapies in Type 1 Diabetes Mellitus (T1D) in the Pre Stage 1 (Before Islet Autoantibodies)”. Acta Scientific Paediatrics 3.6 (2020): 01-04.
Copyright: © 2020 Kulvinder Kochar Kaur. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.